ArticleBMC infectious diseases2025
Investigating Google Trends to forecast acute febrile illness outbreaks in North India reported through the Integrated Disease Surveillance Program.
Article in BMC infectious diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundAcute Febrile Illness (AFI) like Malaria, Dengue, Chikungunya, and Enteric fever still remain the most common cause of seeking healthcare in low-middle-income countries and need to be constantly monitored for any impending outbreak. Digital epidemiology promises to assist traditional health surveillance. The health data (including AFI) collated by Google using specialised platforms like Google Trends (GT) is known to correlate with actual disease trends. The present study thus aims to assess the potential of GT to support routine surveillance system and forecast AFI outbreaks reported through the Indian Integrated Disease Surveillance Programme (IDSP).
methodsWe utilised Haryana's IDSP portal to retrieve the weekly data of the most commonly reported infectious diseases causing AFI between 2011 and 2020. Internet search trends were downloaded using GT. Descriptive statistics estimated the burden of the AFI and Bland-Altman's plot depicted statistical agreement between the two. We adopted the Box-Jenkins approach to attain the final SARIMA model and explain the time-dependent weekly incidence of AFI.
resultsThe time series plot of the reported AFI displayed trends. Martin- Bland plots depicted acceptable agreement between two datasets for all Chikungunya and Dengue. Among the models evaluated, the Malaria model [SARIMA(1,1,1)(1,1,1)] demonstrated the best performance with a balanced fit and reasonable accuracy, while the Enteric Fever model [SARIMA(0,1,0)(1,1,1)] exhibited low prediction error but weak seasonal significance. In contrast, the Dengue [SARIMA(1,1,0)(1,1,0)] and Chikungunya [ARIMA(1,0,0)(0,0,0)] models had high forecast errors, limiting their predictive reliability. Overall, GT supplemented the prediction performance of the SARIMA models with adjusted R
conclusionsOur study observed modest improvements in GT-based SARIMA forecasting models compared to routine IDSP mechanisms for predicting AFI outbreaks in Haryana, highlighting the potential for further enhancement. As more granular GT data becomes available, its integration with traditional surveillance systems could significantly enhance forecasting accuracy for AFI and other infectious disease outbreaks. At no additional cost to the health system, GT can serve as a valuable, real-time digital epidemiology tool, strengthening public health preparedness and enabling timely interventions for the early containment of emerging diseases.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.